DR. DAVID GIACINTO FORCIONE, M.D.
Osteopathic Medicine at Fruit St, Boston, MA

License number
Massachusetts 203897
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address 2
55 Fruit St, Boston, MA 02114
761 Lowell St, Peabody, MA 01960
Phone
(617) 724-6004
(978) 535-0225

Professional information

David G Forcione Photo 1

Dr. David G Forcione, Boston MA - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
GI Associates
55 Fruit St STE 465, Boston 02114
(617) 726-4467 (Phone)
Certifications:
Gastroenterology, 2004, Internal Medicine, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
GI Associates
55 Fruit St STE 465, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
Boston University School Of Medicine
Graduated: 1998
Massachusetts General Hospital
Mass Genl Hospital


David Giacinto Forcione Photo 2

David Giacinto Forcione, Boston MA

Specialties:
Gastroenterologist
Address:
55 Fruit St, Boston, MA 02114
Education:
Boston University, School of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Gastroenterology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)


David Forcione Photo 3

Association Of Mhc Class Ii Allenles And Cancer

US Patent:
2002016, Oct 31, 2002
Filed:
Feb 8, 2002
Appl. No.:
10/049251
Inventors:
Shiv Pillai - Lexington MA, US
Cariappa Annaiah - Marlborough MA, US
David Forcione - West Peabody MA, US
Subhra Chaudhuri - Madison CT, US
International Classification:
A61K039/395, C12Q001/68
US Classification:
424/155100, 435/006000
Abstract:
Particular HLA alleles are found to be associated with human cancer Some HLA alleles are negatively associated with cancer, whereas others show a positive association. This discovery suggests that the immune system plays an important role in the detection and elimination of human tumors. The invention includes methods of determining susceptibility to cancer as well as prognosis. The invention further includes methods of treatment of cancer wherein expression of a particular HLA allele is modulated